Sergey Ryazanov
- Neurology top 2%
- Physiology top 10%
- Cellular and Molecular Neuroscience top 10%
- Molecular Biology
- Neurology top 10%
- Co-authors
- Christian GriesingerAndrei LeonovArmin GieseDaniel WeckbeckerFelix SchmidtGregor K. WenningNadia StefanovaAntonio Heras‐Garvin
- Topics
- Parkinson's Disease Mechanisms and Treatments (14 papers)Alzheimer's disease research and treatments (9 papers)Neurological disorders and treatments (5 papers)
- Partner nations
- GermanyAustriaUnited Kingdom
In The Last Decade
Sergey Ryazanov
24 papers receiving 797 citations
Peers
Comparison fields: 5 of 63
- Neurology 502
- Physiology 363
- Cellular and Molecular Neuroscience 254
- Molecular Biology 242
- Neurology 110
Countries citing papers authored by Sergey Ryazanov
This map shows the geographic impact of Sergey Ryazanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Ryazanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Ryazanov more than expected).
Fields of papers citing papers by Sergey Ryazanov
This network shows the impact of papers produced by Sergey Ryazanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Ryazanov. The network helps show where Sergey Ryazanov may publish in the future.
Co-authorship network of co-authors of Sergey Ryazanov
This figure shows the co-authorship network connecting the top 25 collaborators of Sergey Ryazanov. A scholar is included among the top collaborators of Sergey Ryazanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey Ryazanov. Sergey Ryazanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 34 | |
| 6 | 57 | |
| 7 | [C-11]MODAG-001-towards a PET tracer targeting alpha-synuclein aggregates | 1 |
| 8 | 23 | |
| 9 | 38 | |
| 10 | 64 | |
| 11 | 55 | |
| 12 | 20 | |
| 13 | 89 | |
| 14 | 10 | |
| 15 | 79 | |
| 16 | 10 | |
| 17 | 24 | |
| 18 | 58 | |
| 19 | 10 | |
| 20 | 55 |
About Sergey Ryazanov
Sergey Ryazanov is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology, having authored 27 papers that have together received 809 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (14 papers), Alzheimer's disease research and treatments (9 papers) and Neurological disorders and treatments (5 papers). The work is most often cited by research in Neurology (502 citations), Physiology (363 citations) and Cellular and Molecular Neuroscience (254 citations). Sergey Ryazanov has collaborated with scholars based in Germany, Austria and United Kingdom. Frequent co-authors include Christian Griesinger, Andrei Leonov, Armin Giese, Daniel Weckbecker, Felix Schmidt, Gregor K. Wenning, Nadia Stefanova, Antonio Heras‐Garvin, Stephanie Ghio and Frits Kamp. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.